Overview
Seiichi Hashida practices practicing medicine in Japan.
His clinical expertise encompasses Wilson Disease, Diabetic Nephropathy, and Maturity Onset Diabetes of the Young.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Seiichi Hashida
Is Seiichi Hashida a top-rated expert for Wilson Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Seiichi Hashida is classified as an Experienced expert for Wilson Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Seiichi Hashida participate in research or clinical trials?
Yes. Seiichi Hashida has published 13 articles and abstracts on conditions like Wilson Disease. You can view a list of Seiichi Hashida's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Diabetic NephropathyMr. Hashida isExperienced. Learn about Diabetic Nephropathy.
- Maturity Onset Diabetes of the YoungMr. Hashida isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Wilson DiseaseMr. Hashida isExperienced. Learn about Wilson Disease.